Reviva Pharmaceuticals (NASDAQ:RVPH) is a biopharmaceutical company engaged in the development of innovative therapies for patients with diseases that have significant unmet medical needs, focusing on areas such as the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. Reviva is committed to the discovery and development of new medications aimed at bettering patient outcomes and providing significant improvements over existing therapies. The company's primary objectives include advancing its lead drug candidates through clinical trials, securing partnerships for distribution and marketing, and constantly expanding its pipeline through research and development to address a wide range of medical conditions.